Invention Application
- Patent Title: COMBINATION THERAPIES COMPRISING ANTIBODY MOLECULES TO TIM-3
-
Application No.: US17478370Application Date: 2021-09-17
-
Publication No.: US20220133889A1Publication Date: 2022-05-05
- Inventor: Glenn Dranoff , Catherine Anne Sabatos-Peyton , Barbara Brannetti , Alan S. Harris , Thomas Huber , Thomas Pietzonka , Jennifer Marie Mataraza , Walter A. Blattler , Daniel J. Hicklin , Maximiliano Vasquez , Rosemarie H. DeKruyff , Dale T. Umetsu , Gordon James Freeman , Tiancen Hu , John A. Taraszka , Fangmin Xu
- Applicant: Novartis AG , DANA-FARBER CANCER INSTITUTE, INC. , The Children's Medical Center Corporation
- Applicant Address: CH Basel; US MA Boston; US MA Boston
- Assignee: Novartis AG,DANA-FARBER CANCER INSTITUTE, INC.,The Children's Medical Center Corporation
- Current Assignee: Novartis AG,DANA-FARBER CANCER INSTITUTE, INC.,The Children's Medical Center Corporation
- Current Assignee Address: CH Basel; US MA Boston; US MA Boston
- Main IPC: A61K39/395
- IPC: A61K39/395 ; A61K39/00 ; C07K16/28 ; A61P35/00 ; A61K45/06
Abstract:
Combination therapies comprising antibody molecules that specifically bind to TIM-3 are disclosed. The combination therapies can be used to treat or prevent cancerous or infectious conditions and disorders.
Information query
